The sorted CD26 LSCs from CML patients were confirmed to have the BCR-ABL gene alteration, which is characteristic of CML, in both short-term and long-term colony cells derived from these LSCs. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.